¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20
±³À°ÀÏÀÚ : 2024-04-20
±³À°Àå¼Ò : ·Ôµ¥¿ùµåŸ¿ö SKY31 ÄÁº¥¼Ç

±³À°ÁÖÁ¦ : 2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¸²ÇÁÁ¾¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 10:30~11:05 Basic Concept, Methodology and Preclinical Models of ImmunoPET ÀÌ°æÇÑ(¼º±Õ°üÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 11:05~11:40 Clinical Application of ImmunoPET in Cance °­¼¼·É(Àü³²ÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 11:40~12:30 Clinical Trials and Development Utilizing Generative A ÃÖ¼öÀÎ(°¡Å縯ÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 13:30~14:10 CAR-Engineered T Cell Therapy Stephen J. Schuster (University of Pennsylvania)

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 14:10~14:50 Bispecific Antibody Therapy Georgios Spitadakis(Roche)

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 15:10~15:45 Novel Monoclonal Antibodies and Antibody-Drug Conjugates À¯ÄèÇÑ(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 15:45~16:20 CAR-Engineered T Cell Therapy Àü¿ë¿ì(°¡Å縯ÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 16:20~16:55 Bispecific Antibody Therapy Á¤Á¾Çå(±¹¸³¾Ï¼¾ÅÍ )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-04-20
´ÙÀ½±Û Á¦4Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾ö : 2024-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20387 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ 2024 The 1st BPH Innovation Forum : 2024-04-20 0 124 2024-04-15
20386 ¼­¿ï Á¦1Â÷ ±¹Á¦ÀÏÂ÷ÀÇ·áÇмú´ëȸ ¡¤ 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-04-19 0 115 2024-04-15
20385 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¼­½Ä ÀÛ¼º ½ÇÁ¦) : 2024-04-19 0 119 2024-04-15
20384 °æ±â ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ³úÇ÷°ü ÁúȯÀÇ ÃֽŠġ·á update : 2024-04-19 0 178 2024-04-15
20383 ¼­¿ï ´ëÇѺñ°úÇÐȸ The 31th SNUH International Course on Endoscopic Surgery of the Nose and Paranasal Sinuses in conjunction with International Congress of ORL-HNS 2024 : 2024-04-19 0 155 2024-04-15
20382 ¼­¿ï ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ) 4¿ù ¿ù·ÊÁý´ãȸ : 2024-04-18 0 109 2024-04-15
20381 ÀüºÏ ±º»ê½ÃÀÇ»çȸ ¿¬¼ö±³À°(°Ç°­°ËÁø°á°úÀÇ Çؼ®°ú ´ç´¢º´ ¿¹¹æ, ½ÄµµÁúȯ) : 2024-04-18 0 115 2024-04-15
20380 ¼­¿ï ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) The 11th KSN Live Academy : 2024-04-18 0 108 2024-04-15
20379 ±¤ÁÖ 2023 Á¦11ȸ ±¤ÁÖ¡¤Àü³² Áöȸ ½ÉÆ÷Áö¿ò : 2024-04-18 0 195 2024-04-15
20378 °æ±â ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(ÀÎÈĵοª·ùÁúȯ) : 2024-05-31 0 225 2024-04-12
20377 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ IFFAS 2024 (2ÀÏÂ÷) : 2024-05-31 0 163 2024-04-12
20376 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¾Ë·¹¸£±âºñ¿°ÀÇ ¾à¹°Ä¡·á½Ã ²À ¾Ë¾Æ¾ß ÇÒ »çÇ× : 2024-05-30 0 173 2024-04-12
20375 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ IFFAS 2024 (1ÀÏÂ÷) : 2024-05-30 0 119 2024-04-12
20374 ¼­¿ï Á¦43Â÷ ´ëÇѼöÇ÷ÇÐȸ Çмú´ëȸ : 2024-05-30 0 131 2024-04-12
20373 ¼­¿ï International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY3 : 2024-05-29 0 112 2024-04-12
51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷